Skip to content
Search

Latest Stories

New Covid strain Stratus spreads in UK with unusual hoarse voice symptom

According to data from the UK Health Security Agency (UKHSA)

New Covid strain

Experts have raised concerns about the immune-evasive nature of the Stratus strain

iStock

Key points

  • A new Covid strain known as Stratus is spreading across the UK
  • The variant is marked by a distinctive symptom: a hoarse or raspy voice
  • Sub-variants XFG and XFG.3 now account for 30% of cases in England
  • Experts say there is no evidence of more severe disease
  • Lower immunity levels may make more people vulnerable to infection

Covid variant Stratus on the rise in the UK

A new strain of Covid-19, known as Stratus, is spreading across the UK and drawing attention for its unusual symptom — a hoarse or raspy voice. According to data from the UK Health Security Agency (UKHSA), Stratus and its two sub-variants, XFG and XFG.3, are responsible for around 30 per cent of Covid cases in England.

Of the two, XFG.3 is currently the more dominant. The UKHSA confirmed that monitoring of all circulating Covid-19 variants is ongoing as part of regular surveillance.


Mutations help Stratus spread despite immunity

Experts have raised concerns about the immune-evasive nature of the Stratus strain. Dr Kaywaan Khan, a Harley Street GP and founder of Hannah London Clinic, noted that certain mutations in the spike protein could help the virus bypass antibodies generated by previous infection or vaccination.

“Unlike other variants, Stratus has certain mutations in the spike protein which could help it evade antibodies developed from prior infections or vaccinations,” said Dr Khan. However, the symptoms tend to remain mild to moderate, with hoarseness being one of the most noticeable.

Dr Alex Allen, Consultant Epidemiologist at the UKHSA, said, “It is normal for viruses to mutate and change over time,” adding that there is currently no evidence that the XFG or XFG.3 variants cause more severe disease than previous strains.

Waning immunity raises infection risk

According to Professor Lawrence Young, a virologist at the University of Warwick, the reduction in Covid-19 infections in recent months, along with lower booster jab uptake, could increase the risk of infection.

“Given that immunity to Covid is waning in the population due to a decline in uptake of the spring booster jab and the reduction of Covid infections in recent months, more people will be susceptible to infection with XFG and XFG.3,” he told MailOnline.

He warned that this could lead to a new wave of infections, though the scale remains uncertain.

Global monitoring of the strain

Globally, Stratus accounted for 22.7 per cent of Covid cases as of 22 June, according to the World Health Organisation (WHO). The strain has been designated as a “variant under monitoring”, with WHO currently assessing its public health impact as low risk.

The emergence of Stratus follows the spread of another recent variant called Nimbus (NB.1.8.1), first detected in China and Hong Kong in January and now present in parts of the US and Australia. Nimbus has been associated with more severe sore throat symptoms.

Reduced testing levels since the pandemic’s peak make it difficult to track the true spread of these new variants, health officials have noted.

More For You

Monica Seles

Seles first began noticing symptoms around five years ago

Getty Images

Tennis champion Monica Seles reveals living with myasthenia gravis

Highlights:

  • Nine-time Grand Slam winner Monica Seles diagnosed with myasthenia gravis three years ago
  • The 51-year-old revealed her condition ahead of this month’s US Open to raise awareness
  • Disease causes muscle weakness and has no known cure

Former world number one Monica Seles has revealed she was diagnosed with myasthenia gravis, a rare neuromuscular autoimmune disease, three years ago. The 51-year-old, who won nine Grand Slam singles titles, went public ahead of the US Open to raise awareness of the condition, which causes muscle weakness and can affect multiple parts of the body.

Symptoms and diagnosis

Seles first began noticing symptoms around five years ago when she experienced double vision and struggled with coordination. “I would be playing [tennis] with some kids or family members, and I would miss a ball. I was like, ‘Yeah, I see two balls,’” she told the Associated Press. These symptoms eventually led to her diagnosis, which took time for her to come to terms with.

Keep ReadingShow less
health

A 34-year-old woman developed 43 aggressive skin cancer lesions triggered by HPV

iStock

Oral sex linked to skin cancer risk through stealth HPV infections, scientists warn

Highlights:

  • HPV, a common STI, is now potentially linked to a deadly form of skin cancer
  • A 34-year-old woman developed 43 aggressive skin cancer lesions triggered by HPV
  • Researchers say this discovery could shift the approach to diagnosing and treating some skin cancers
  • Protection measures include vaccination, safe sex practices, and regular screening


Human papillomavirus (HPV), one of the most widespread sexually transmitted infections in the UK, is already associated with several serious cancers — cervical, throat, penile, anal, and head and neck cancers among them. Now, researchers in the US have raised concerns that it may also contribute to certain forms of skin cancer, especially in people with weakened immune systems.

Scientists from the National Institutes of Health (NIH) found signs of beta-HPV triggering squamous cell carcinoma in a young woman who had no major history of sun damage or other typical causes.

Keep ReadingShow less
CardioPrecision

The approach aims to reduce pain, shorten hospital stays, and improve patient outcomes

MediaZoo

CardioPrecision performs world-first robot-assisted aortic valve replacement via neck incision

Highlights:

  • Glasgow-based CardioPrecision completes first clinical cases of robotic aortic valve replacement (AVR) through a small neck incision.
  • The procedure was carried out at Cleveland Clinic in the United States.
  • It uses the company’s CoreVista® Robot Enabling Platform to perform minimally invasive surgery.
  • The approach aims to reduce pain, shorten hospital stays, and improve patient outcomes.
  • Early results presented at major international conferences show clinical promise.


Glasgow medtech firm CardioPrecision has successfully performed the world’s first clinical cases of robot-assisted aortic valve replacement (AVR) using a small transcervical incision. This breakthrough could significantly reduce the need for traditional open-heart surgery.

The pioneering operations were carried out at the Cleveland Clinic in the United States, a centre globally recognised for its cardiovascular care. The procedures used CardioPrecision’s proprietary CoreVista® Robot Enabling Platform, offering a new route for accessing the heart valve via the neck rather than the chest.

Keep ReadingShow less
Chikungunya outbreak China 2025

Chikungunya is not contagious between people

Getty Images

Chikungunya virus outbreak in China: What you need to know

Highlights:

  • Over 7,000 chikungunya cases reported in southern China, mainly Guangdong province
  • Virus spread rapidly after an imported case was detected in Foshan on 8 July
  • Authorities enforcing hospital quarantine and door-to-door inspections
  • Chikungunya is mosquito-borne and not transmitted person to person
  • CDC issues travel alert; UK yet to release guidance

A mosquito-borne virus is spreading rapidly in China, with more than 7,000 people infected across at least 13 cities in Guangdong province. Authorities are introducing containment measures reminiscent of the Covid pandemic in an effort to stop the virus’s spread—even though chikungunya cannot be transmitted between people.

The outbreak began in Foshan, north of Hong Kong, where an imported case was confirmed on 8 July. The city has since recorded nearly 3,000 cases in just one week, according to Chinese media and international reporting.

Keep ReadingShow less
Mounjaro

Long-term lifestyle changes and support are essential for sustained weight loss

iStock

Mounjaro patients need more support after treatment, health experts say

Highlights:

  • NICE warns that patients risk regaining weight after stopping jabs like Mounjaro and Wegovy
  • NHS patients should receive structured support for at least a year after treatment
  • Private users, who make up the majority, are not eligible for NHS follow-up
  • Around 240,000 NHS patients will receive Mounjaro over the next three years
  • Long-term lifestyle changes and support are essential for sustained weight loss


Patients using popular weight-loss jabs, including Mounjaro (tirzepatide), are being warned about the risk of regaining weight once treatment ends. The National Institute for Health and Care Excellence (NICE) is urging health services to provide structured support and follow-up care, particularly for those accessing the drugs via the NHS.

New guidance from NICE stresses the importance of offering advice and continued monitoring to prevent weight gain after medication ends, stating that patients should not be left without support during this crucial transition period.

Keep ReadingShow less